By Elias Schisgall

Shares of Aurora Cannabis fell after the company posted a loss in its fiscal third quarter as sales in its consumer cannabis were nearly cut in half.

Shares fell 9% to $3.70 midday Wednesday after hitting a 52-week low of $3.68 earlier in the session. The stock is roughly flat over the past year.

The Canadian cannabis company said Wednesday that it would exit certain markets in the consumer cannabis segment, where revenue fell 48% year over year. The exit, beginning during the current fourth quarter, is expected to lead to lower adjusted sales and cost savings, the company said.

Aurora said it will focus on its higher-margin global medical cannabis business, where revenue rose 12% during the quarter ended Dec. 31. The company's plant propagation segment posted 27% growth.

The company posted a net loss of 1.7 Canadian dollars ($1.2 million), compared with a profit of C$28.1 million a year earlier.

Total revenue grew to C$94.2 million, compared with C$88.2 million a year earlier. Analysts polled by FactSet were expecting C$92.4 million.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

February 04, 2026 12:22 ET (17:22 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.